Dragonfly, Therapeutics

Dragonfly Therapeutics inicia el estudio de fase 1/ 1b de su inmunoterapia con IL-2

07.08.2025 - 18:03:25 | prnewswire.co.uk

Dragonfly Therapeutics, Inc. Massachusetts

View original content:https://www.prnewswire.com/news-releases/dragonfly-therapeutics-inicia-el-estudio-de-fase-11b-de-su-inmunoterapia-con-il-2-302006807.html

en | boerse | 67997223 |